Scan data collected during image-guided cancer treatments in adults
Collects scan data from adults receiving image-guided treatment for liver, lung, kidney or bone cancer.
Plain-language title generated from the registry record
Registry title: Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance
Key facts
- Where
- Créteil and Lyon, FranceSee the 2 sites
Where in France
- Assistance Publique Hopitaux de Paris - Hôpital Henri MondorCréteil, FranceNot yet recruiting
- Hospices Civils de Lyon - Hôpital Édouard HerriotLyon, FranceNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Mark C Burgmans, MD PhD
- Trial code
- NCT07636148
- Record updated
- 1 September 2026
- Original description
This study collects data from patients undergoing minimally invasive, image-guided cancer treatments at participating hospitals in the Netherlands and France. All treatments are performed as standard clinical care and include procedures such as tumor ablation and catheter-based treatments of cancer in the liver, kidney, lung, and bone.Read full original descriptionShow less
Prospective Registry of Spectral Angio-CT-Guided Interventional Oncology Procedures in Routine Clinical Practice
This study collects data from patients undergoing minimally invasive, image-guided cancer treatments at participating hospitals in the Netherlands and France. All treatments are performed as standard clinical care and include procedures such as tumor ablation and catheter-based treatments of cancer in the liver, kidney, lung, and bone.
During these procedures, a spectral angio-CT system is used for image guidance. This advanced CT scanner automatically captures additional imaging information beyond what is used in routine clinical decision-making. The goal of this study is to investigate how this additional imaging information is associated with treatment outcomes, and how it can be used in the future to improve treatment planning, procedural guidance, and prediction of treatment results.
No experimental interventions are performed. Participation does not alter the treatment or follow-up patients receive. Data are collected from medical records and imaging systems and stored securely for analysis.
Inclusion: Age ≥ 18 years; Undergoing a clinically indicated IO procedure with a percutaneous or transarterial approach for solid tumors; Use of spectral angio-CT image guidance as part of standard care; Written confirmed consent.
Exclusion: Patients suffering from psychic disorders that make a comprehensive judgement impossible; Patients who are declared incapacitated.